{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:29:48Z","timestamp":1793312988904,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.7759\/cureus.78944","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:40:27Z","timestamp":1739461227000},"source":"Crossref","is-referenced-by-count":4,"title":["Chronic Hepatitis B Virus Persistence: Mechanisms and Insights"],"prefix":"10.7759","author":[{"given":"Samrita","family":"Naidu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Margeridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","author":"The Polaris Observatory Collaborators","year":"2023","unstructured":"The Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023, 8:879-907. 10.1016\/s2468-1253(23)00197-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","unstructured":"WHO. Hepatitis B. (2024). Accessed. August 11, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.07.019","article-title":"Deciphering the origin and evolution of hepatitis B viruses by means of a family of non-enveloped fish viruses","volume":"22","author":"Lauber C","year":"2017","unstructured":"Lauber C, Seitz S, Mattei S, et al.. Deciphering the origin and evolution of hepatitis B viruses by means of a family of non-enveloped fish viruses. Cell Host Microbe. 2017, 22:387-99.e6. 10.1016\/j.chom.2017.07.019","journal-title":"Cell Host Microbe"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/v13050757","article-title":"Early steps of hepatitis B life cycle: from capsid nuclear import to cccDNA formation","volume":"13","author":"Diogo Dias J","year":"2021","unstructured":"Diogo Dias J, Sarica N, Neuveut C. Early steps of hepatitis B life cycle: from capsid nuclear import to cccDNA formation. Viruses. 2021, 13:757. 10.3390\/v13050757","journal-title":"Viruses"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32314","article-title":"Getting to HBV cure: the promising paths forward","volume":"76","author":"Fung S","year":"2022","unstructured":"Fung S, Choi HS, Gehring A, Janssen HL. Getting to HBV cure: the promising paths forward. Hepatology. 2022, 76:233-50. 10.1002\/hep.32314","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/v13081463","article-title":"Mechanism of hepatitis B virus cccDNA formation","volume":"13","author":"Wei L","year":"2021","unstructured":"Wei L, Ploss A. Mechanism of hepatitis B virus cccDNA formation. Viruses. 2021, 13:1463. 10.3390\/v13081463","journal-title":"Viruses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei L","year":"2021","unstructured":"Wei L, Ploss A. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand. Nat Commun. 2021, 12:1591. 10.1038\/s41467-021-21850-9","journal-title":"Nat Commun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation and therapeutic potential","volume":"180","author":"Xia Y","year":"2020","unstructured":"Xia Y, Guo H. Hepatitis B virus cccDNA: formation, regulation and therapeutic potential. Antiviral Res. 2020, 180:104824. 10.1016\/j.antiviral.2020.104824","journal-title":"Antiviral Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long Q","year":"2017","unstructured":"Long Q, Yan R, Hu J, et al.. The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation. PLoS Pathog. 2017, 13:e1006784. 10.1371\/journal.ppat.1006784","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger P","year":"2015","unstructured":"Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE, Holdorf M. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci U S A. 2015, 112:E5715-24. 10.1073\/pnas.1518090112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c02216","article-title":"HBV cccDNA\u2500a culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure","volume":"7","author":"Bhat SA","year":"2022","unstructured":"Bhat SA, Kazim SN. HBV cccDNA\u2500a culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure. ACS Omega. 2022, 7:24066-81. 10.1021\/acsomega.2c02216","journal-title":"ACS Omega"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance","volume":"9","author":"Allweiss L","year":"2017","unstructured":"Allweiss L, Dandri M. The role of cccDNA in HBV maintenance. Viruses. 2017, 9:156. 10.3390\/v9060156","journal-title":"Viruses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biom13081208","article-title":"Chronic hepatitis B infection: new approaches towards cure","volume":"13","author":"Ogunnaike M","year":"2023","unstructured":"Ogunnaike M, Das S, Raut SS, et al.. Chronic hepatitis B infection: new approaches towards cure. Biomolecules. 2023, 13:1208. 10.3390\/biom13081208","journal-title":"Biomolecules"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill PA","year":"2019","unstructured":"Revill PA, Chisari FV, Block JM, et al.. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019, 4:545-58. 10.1016\/S2468-1253(19)30119-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174276","article-title":"Mapping the interactions of HBV cccDNA with host factors","volume":"20","author":"Mohd-Ismail NK","year":"2019","unstructured":"Mohd-Ismail NK, Lim Z, Gunaratne J, Tan YJ. Mapping the interactions of HBV cccDNA with host factors. Int J Mol Sci. 2019, 20:4276. 10.3390\/ijms20174276","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong GL","year":"2022","unstructured":"Wong GL, Gane E, Lok AS. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?. J Hepatol. 2022, 76:1249-62. 10.1016\/j.jhep.2021.11.024","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/v12020160","article-title":"Host transcription factors in hepatitis B virus RNA synthesis","volume":"12","author":"Turton KL","year":"2020","unstructured":"Turton KL, Meier-Stephenson V, Badmalia MD, Coffin CS, Patel TR. Host transcription factors in hepatitis B virus RNA synthesis. Viruses. 2020, 12:160. 10.3390\/v12020160","journal-title":"Viruses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.795388","article-title":"KAT2A promotes hepatitis B virus transcription and replication through epigenetic regulation of cccDNA minichromosome","volume":"12","author":"Qin YP","year":"2021","unstructured":"Qin YP, Yu HB, Yuan SY, et al.. KAT2A promotes hepatitis B virus transcription and replication through epigenetic regulation of cccDNA minichromosome. Front Microbiol. 2021, 12:795388. 10.3389\/fmicb.2021.795388","journal-title":"Front Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.11.085","article-title":"Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells","volume":"482","author":"Kinoshita W","year":"2017","unstructured":"Kinoshita W, Ogura N, Watashi K, Wakita T. Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells. Biochem Biophys Res Commun. 2017, 482:638-44. 10.1016\/j.bbrc.2016.11.085","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/v15051178","article-title":"Super-resolution microscopy analysis of hepatitis B viral cccDNA and host factors","volume":"15","author":"Doan PT","year":"2023","unstructured":"Doan PT, Nio K, Shimakami T, et al.. Super-resolution microscopy analysis of hepatitis B viral cccDNA and host factors. Viruses. 2023, 15:1178. 10.3390\/v15051178","journal-title":"Viruses"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319637","article-title":"Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription","volume":"69","author":"Salerno D","year":"2020","unstructured":"Salerno D, Chiodo L, Alfano V, et al.. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020, 69:2016-24. 10.1136\/gutjnl-2019-319637","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105796","article-title":"Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3","volume":"221","author":"Ming T","year":"2024","unstructured":"Ming T, Yuting L, Meiling D, et al.. Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3. Antiviral Res. 2024, 221:105796. 10.1016\/j.antiviral.2024.105796","journal-title":"Antiviral Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.836446","article-title":"SIRT2 promotes HBV transcription and replication by targeting transcription factor p53 to increase the activities of HBV enhancers and promoters","volume":"13","author":"Wu DQ","year":"2022","unstructured":"Wu DQ, Ding QY, Tao NN, et al.. SIRT2 promotes HBV transcription and replication by targeting transcription factor p53 to increase the activities of HBV enhancers and promoters. Front Microbiol. 2022, 13:836446. 10.3389\/fmicb.2022.836446","journal-title":"Front Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04852-3","article-title":"PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA","volume":"13","author":"Fan Y","year":"2022","unstructured":"Fan Y, Liang Y, Liu Y, Fan H. PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA. Cell Death Dis. 2022, 13:404. 10.1038\/s41419-022-04852-3","journal-title":"Cell Death Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.08.002","article-title":"cccDNA surrogate MC-HBV-based screen identifies cohesin complex as a novel HBV restriction factor","volume":"14","author":"Wu Z","year":"2022","unstructured":"Wu Z, Wang L, Wang X, et al.. cccDNA surrogate MC-HBV-based screen identifies cohesin complex as a novel HBV restriction factor. Cell Mol Gastroenterol Hepatol. 2022, 14:1177-98. 10.1016\/j.jcmgh.2022.08.002","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00767-21","article-title":"MafF is an antiviral host factor that suppresses transcription from hepatitis B virus core promoter","volume":"95","author":"Ibrahim MK","year":"2021","unstructured":"Ibrahim MK, Abdelhafez TH, Takeuchi JS, et al.. MafF is an antiviral host factor that suppresses transcription from hepatitis B virus core promoter. J Virol. 2021, 95:e0076721. 10.1128\/JVI.00767-21","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306810","article-title":"HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1\/2 deacetylase complex to cccDNA minichromosome","volume":"11","author":"Qin Y","year":"2024","unstructured":"Qin Y, Ren J, Yu H, et al.. HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1\/2 deacetylase complex to cccDNA minichromosome. Adv Sci (Weinh). 2024, 11:e2306810. 10.1002\/advs.202306810","journal-title":"Adv Sci (Weinh)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.009","article-title":"Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication","volume":"72","author":"Wang YX","year":"2020","unstructured":"Wang YX, Niklasch M, Liu T, et al.. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. J Hepatol. 2020, 72:865-76. 10.1016\/j.jhep.2019.12.009","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3746628","article-title":"Mapping cccDNA-host interactome identifies cohesin complex as a novel HBV restriction factor","volume":"14","author":"Wu Z","year":"2022","unstructured":"Wu Z, Wang L, Wang X, et al.. Mapping cccDNA-host interactome identifies cohesin complex as a novel HBV restriction factor. SSRN Electronic J. 2022, 14:1177-98. 10.2139\/ssrn.3746628","journal-title":"SSRN Electronic J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030498","article-title":"Ca2+\/calmodulin-dependent protein kinase II inhibits hepatitis B virus replication from cccDNA via AMPK activation and AKT\/mTOR suppression","volume":"10","author":"Kim J","year":"2022","unstructured":"Kim J, Kwon H, Kalsoom F, et al.. Ca2+\/calmodulin-dependent protein kinase II inhibits hepatitis B virus replication from cccDNA via AMPK activation and AKT\/mTOR suppression. Microorganisms. 2022, 10:498. 10.3390\/microorganisms10030498","journal-title":"Microorganisms"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00442-20","article-title":"Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription","volume":"94","author":"Cheng J","year":"2020","unstructured":"Cheng J, Zhao Q, Zhou Y, Tang L, Sheraz M, Chang J, Guo JT. Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription. J Virol. 2020, 94:10.1128\/JVI.00442-20","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i23.3182","article-title":"Silencing hepatitis B virus covalently closed circular DNA: the potential of an epigenetic therapy approach","volume":"27","author":"Singh P","year":"2021","unstructured":"Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: the potential of an epigenetic therapy approach. World J Gastroenterol. 2021, 27:3182-207. 10.3748\/wjg.v27.i23.3182","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01345-23","article-title":"Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus","volume":"98","author":"Shen Z","year":"2024","unstructured":"Shen Z, Zhang S, Gao Z, et al.. Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus. J Virol. 2024, 98:e0134523. 10.1128\/jvi.01345-23","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103135","article-title":"LINC01431 promotes histone H4R3 methylation to impede HBV covalently closed circular DNA transcription by stabilizing PRMT1","volume":"9","author":"Sun Y","year":"2022","unstructured":"Sun Y, Teng Y, Wang L, et al.. LINC01431 promotes histone H4R3 methylation to impede HBV covalently closed circular DNA transcription by stabilizing PRMT1. Adv Sci (Weinh). 2022, 9:e2103135. 10.1002\/advs.202103135","journal-title":"Adv Sci (Weinh)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/v16050764","article-title":"Intracellular host restriction of hepatitis B virus replication","volume":"16","author":"Sinha P","year":"2024","unstructured":"Sinha P, Thio CL, Balagopal A. Intracellular host restriction of hepatitis B virus replication. Viruses. 2024, 16:764. 10.3390\/v16050764","journal-title":"Viruses"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314255","article-title":"Chronic hepatitis B: divide and conquer?","volume":"67","author":"Nassal M","year":"2018","unstructured":"Nassal M. Chronic hepatitis B: divide and conquer?. Gut. 2018, 67:400-2. 10.1136\/gutjnl-2017-314255","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100514","article-title":"Mitosis of hepatitis B virus-infected cells in\u00a0vitro results in uninfected daughter cells","volume":"4","author":"Tu T","year":"2022","unstructured":"Tu T, Zehnder B, Wettengel JM, et al.. Mitosis of hepatitis B virus-infected cells in\u00a0vitro results in uninfected daughter cells. JHEP Rep. 2022, 4:100514. 10.1016\/j.jhepr.2022.100514","journal-title":"JHEP Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00722-18","article-title":"Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype","volume":"92","author":"Xia Y","year":"2018","unstructured":"Xia Y, Cheng X, Li Y, Valdez K, Chen W, Liang TJ. Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype. J Virol. 2018, 92:10.1128\/JVI.00722-18","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.12.089","article-title":"Blocking of G1\/S transition and cell death in the regenerating liver of hepatitis B virus X protein transgenic mice","volume":"340","author":"Wu BK","year":"2006","unstructured":"Wu BK, Li CC, Chen HJ, et al.. Blocking of G1\/S transition and cell death in the regenerating liver of hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun. 2006, 340:916-28. 10.1016\/j.bbrc.2005.12.089","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00213.x","article-title":"Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses","volume":"38","author":"Chen HY","year":"2008","unstructured":"Chen HY, Tang NH, Lin N, Chen ZX, Wang XZ. Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses. Hepatol Res. 2008, 38:174-82. 10.1111\/j.1872-034X.2007.00213.x","journal-title":"Hepatol Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12439","article-title":"Immunobiology of hepatitis B virus infection","volume":"45","author":"Isogawa M","year":"2015","unstructured":"Isogawa M, Tanaka Y. Immunobiology of hepatitis B virus infection. Hepatol Res. 2015, 45:179-89. 10.1111\/hepr.12439","journal-title":"Hepatol Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8+ T cells in hepatitis B virus infection","volume":"5","author":"Schuch A","year":"2014","unstructured":"Schuch A, Hoh A, Thimme R. The role of natural killer cells and CD8+ T cells in hepatitis B virus infection. Front Immunol. 2014, 5:258. 10.3389\/fimmu.2014.00258","journal-title":"Front Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti LG","year":"1999","unstructured":"Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999, 284:825-9. 10.1126\/science.284.5415.825","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","author":"Webster GJ","year":"2000","unstructured":"Webster GJ, Reignat S, Maini MK, et al.. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology. 2000, 32:1117-24. 10.1053\/jhep.2000.19324","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn C","year":"2009","unstructured":"Dunn C, Peppa D, Khanna P, et al.. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology. 2009, 137:1289-300. 10.1053\/j.gastro.2009.06.054","journal-title":"Gastroenterology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.06.015","article-title":"Hepatitis B virus antigens impair NK cell function","volume":"38","author":"Yang Y","year":"2016","unstructured":"Yang Y, Han Q, Zhang C, Xiao M, Zhang J. Hepatitis B virus antigens impair NK cell function. Int Immunopharmacol. 2016, 38:291-7. 10.1016\/j.intimp.2016.06.015","journal-title":"Int Immunopharmacol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero B","year":"2009","unstructured":"Oliviero B, Varchetta S, Paudice E, et al.. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology. 2009, 137:1151-60. 10.1053\/j.gastro.2009.05.047","journal-title":"Gastroenterology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li H","year":"2018","unstructured":"Li H, Zhai N, Wang Z, et al.. Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection. Gut. 2018, 67:2035-44. 10.1136\/gutjnl-2017-314098","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e30","article-title":"IFN-\u03b3: a crucial player in the fight against HBV infection?","volume":"23","author":"Hillaire ML","year":"2023","unstructured":"Hillaire ML, Lawrence P, Lagrange B. IFN-\u03b3: a crucial player in the fight against HBV infection?. Immune Netw. 2023, 23:e30. 10.4110\/in.2023.23.e30","journal-title":"Immune Netw"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i27.3527","article-title":"Immune suppression in chronic hepatitis B infection associated liver disease: a review","volume":"25","author":"Li TY","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: a review. World J Gastroenterol. 2019, 25:3527-37. 10.3748\/wjg.v25.i27.3527","journal-title":"World J Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa D","year":"2013","unstructured":"Peppa D, Gill US, Reynolds G, et al.. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med. 2013, 210:99-114. 10.1084\/jem.20121172","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202448","article-title":"The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection","volume":"190","author":"Cook KD","year":"2013","unstructured":"Cook KD, Whitmire JK. The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection. J Immunol. 2013, 190:641-9. 10.4049\/jimmunol.1202448","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti LG","year":"1996","unstructured":"Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996, 4:25-36. 10.1016\/s1074-7613(00)80295-2","journal-title":"Immunity"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye B","year":"2015","unstructured":"Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015, 6:e1694. 10.1038\/cddis.2015.42","journal-title":"Cell Death Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1206720","article-title":"Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity","volume":"13","author":"Zheng P","year":"2023","unstructured":"Zheng P, Dou Y, Wang Q. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. Front Cell Infect Microbiol. 2023, 13:1206720. 10.3389\/fcimb.2023.1206720","journal-title":"Front Cell Infect Microbiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.03.69","article-title":"Alpha-interferon treatment in hepatitis B","volume":"5","author":"Woo AS","year":"2017","unstructured":"Woo AS, Kwok R, Ahmed T. Alpha-interferon treatment in hepatitis B. Ann Transl Med. 2017, 5:159. 10.21037\/atm.2017.03.69","journal-title":"Ann Transl Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and hepatitis B: current and future perspectives","volume":"12","author":"Ye J","year":"2021","unstructured":"Ye J, Chen J. Interferon and hepatitis B: current and future perspectives. Front Immunol. 2021, 12:733364. 10.3389\/fimmu.2021.733364","journal-title":"Front Immunol"},{"key":"ref58","unstructured":"Clinical review report. tenofovir alafenamide (Vemlidy). Indication: treatment of chronic hepatitis B in adults with compensated liver disease. (2018). Accessed: August 13, 2024: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK533926\/."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/2325958220919231","article-title":"A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide","volume":"19","author":"Wassner C","year":"2020","unstructured":"Wassner C, Bradley N, Lee Y. A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide. J Int Assoc Provid AIDS Care. 2020, 19:10.1177\/2325958220919231","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref60","article-title":"The role of entecavir in the treatment of chronic hepatitis B","volume":"3","author":"Dimou E","year":"2007","unstructured":"Dimou E, Papadimitropoulos V, Hadziyannis SJ. The role of entecavir in the treatment of chronic hepatitis B. Ther Clin Risk Manag. 2007, 3:1077-86.","journal-title":"Ther Clin Risk Manag"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i46.6150","article-title":"Telbivudine: a new treatment for chronic hepatitis B","volume":"13","author":"Amarapurkar DN","year":"2007","unstructured":"Amarapurkar DN. Telbivudine: a new treatment for chronic hepatitis B. World J Gastroenterol. 2007, 13:6150-5. 10.3748\/wjg.v13.i46.6150","journal-title":"World J Gastroenterol"},{"key":"ref62","unstructured":"PubChem. Adefovir. (2024). Accessed. August 13, 2024: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Adefovir."},{"key":"ref63","article-title":"Lamivudine","author":"Taylor K","year":"2024","unstructured":"Taylor K, Fritz K, Pellegrini MV, et al.. Lamivudine. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref64","article-title":"Emtricitabine","author":"Muller JT","year":"2024","unstructured":"Muller JT, Al Khalili Y. Emtricitabine. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8","author":"Men\u00e9ndez-Arias L","year":"2014","unstructured":"Men\u00e9ndez-Arias L, \u00c1lvarez M, Pacheco B. Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance. Curr Opin Virol. 2014, 8:1-9. 10.1016\/j.coviro.2014.04.005","journal-title":"Curr Opin Virol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1128807","article-title":"The progress of molecules and strategies for the treatment of HBV infection","volume":"13","author":"Pan Y","year":"2023","unstructured":"Pan Y, Xia H, He Y, Zeng S, Shen Z, Huang W. The progress of molecules and strategies for the treatment of HBV infection. Front Cell Infect Microbiol. 2023, 13:1128807. 10.3389\/fcimb.2023.1128807","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341343-chronic-hepatitis-b-virus-persistence-mechanisms-and-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:40:32Z","timestamp":1739461232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341343-chronic-hepatitis-b-virus-persistence-mechanisms-and-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.78944","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}